ClearBridge Mid Cap Strategy outperformed its Russell Midcap Index during the third quarter, driven by standout stock ...

Saguaro Biosciences, a pioneer in non-toxic live cell reagents for enhanced drug insights, announces a new distribution ...

TD Cowen analyst Kyle Boucher raised the firm’s price target on Bio-Techne (TECH) to $70 from $65 and keeps a Buy rating on the shares. The firm ...

ConMed Corp. (NYSE: CNMD), a surgical-device maker originally based in the Mohawk Valley region, recently announced that Kim ...

Ratings for Bio-Techne (NASDAQ: TECH) were provided by 5 analysts in the past three months, showcasing a mix of bullish and ...

Shares of Bio-Techne Corp. shed 4.43% to $59.18 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.38% to 6,714.59 and Dow Jones ...

This year’s A-List shows that the revenues for the top five public companies in spatial biology have risen nine percent from a year ago ...

Among others, the following stocks were impacted: Bio-Techne’s shares are very volatile and have had 21 moves greater than 5% ...

In a report released today, Daniel Arias from Stifel Nicolaus maintained a Buy rating on Repligen, with a price target of $207.00. The company’s shares closed yesterday at $113.74. Take advantage of ...

Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne IRVINE, CA, and HERSTAL, BELGIUM - September 15, 2025 (GlobeNewswire) - MDxHealth SA (NASDAQ: MDXH) (the "Company" or ...

Good morning, and welcome to Bio-Techne's Earnings Conference Call for the Fourth Quarter and Fiscal Year 2025. [Operator Instructions] I would now like to turn the call over to David Clair, ...

(Reuters) -Bio-Techne on Wednesday said it expects uncertainty related to U.S. President Donald Trump's tariff and academic funding policies to spill into its fiscal year 2026 and could create ...